Skip to main navigation Skip to search Skip to main content

Therapeutic potential of Crispr/Cas-9 gene edited apolipoprotein B-null cells and insulin signalling in lipoprotein metabolism

  • Q. Su*
  • , H. Wade
  • *Corresponding author for this work

Research output: Contribution to journal › Meeting abstract › peer-review

Original languageEnglish
Pages (from-to)S413-S414
Number of pages2
JournalDiabetologia
Volume65
DOIs
Publication statusPublished - 03 Aug 2022
Event58th Annual Meeting of the European Association for the Study of Diabetes - Stockholm, Sweden
Duration: 19 Sept 2022 → 23 Sept 2022
https://www.easd.org/annual-meeting/easd-2022.html

Cite this